Name: Presentation by Adam Evans, Janssen: Multi-Attribute Monitoring from Development to Commercial QC
Start: 2021-10-14T08:00:00-07:00
End: 2021-10-14T09:00:00-07:00

September 2020

September 14, 2020 @ 8:00 am - September 17, 2020 @ 1:00 pm

CASSS MS Conference

September 25, 2020 @ 8:00 am - 9:00 am

Presentation by Lucie Manache-Alberici & Cedric Mesmin, Merck Group: Validation of an LC-MS Multi-Attribute Method (MAM) Supporting Biopharma Process Characterization.

November 2020

November 19, 2020 @ 8:00 am - 9:00 am

Presentation by Shawn Li, Merck: Transition of Multi-Attribute Method (MAM) to GMP for biotherapeutics

December 2020

December 18, 2020 @ 8:00 am - 9:00 am

Presentation by Yuting Huang, Pfizer: Accelerating Biotherapeutic Development by Automated MAM

April 2021

April 16, 2021 @ 8:00 am - 9:00 am

Presentation by Camille Lombard-Banek, NIST: Expending MAM Principles to the Characterization of Cell-based Therapies

April 28, 2021 @ 8:00 am - 9:00 am

USP Biologics Open Forum on MAM

May 2021

May 27, 2021 @ 8:00 am - 9:00 am

Presentation by Rich Rogers, BMS: Mass Spectrometry-Based Process Analytical Technologies for Cell Therapies

June 2021

June 11, 2021 @ 8:00 am - 9:00 am

Presentation by Silvia Millán Martín, NIBRT: The role of MAM in advancing innovative analytical strategies for biotherapeutics characterization and the benefits of New Peak Detection

August 2021

August 9, 2021 @ 8:00 am - 9:00 am

Presentation by Mitul Patel, GSK: Incorporating Mass Spectrometry into Analytical Strategies to Early De-risk the mAb Discovery and CMC processes

October 2021

October 14, 2021 @ 8:00 am - 9:00 am